Dean et al. found that IGFBP2 can be used to indicate the PI3K/AKT pathway activation and PTEN status, and participates in the carcinogens of many types of cancer through the cascade with PTEN.57, 58, 59, 60. This evidence concerns the gene AKT1 and cancer.